We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ERS Genomics Announces Agreement With Applied StemCell To Commercialize CRISPR Gene Editing Solutions

Product News   Sep 21, 2020

 
ERS Genomics Announces Agreement With Applied StemCell To Commercialize CRISPR Gene Editing Solutions
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

New Collaboration Explores Efficacy of Gene Delivery Vector Tech in Diabetes and Multiple Sclerosis

Product News

Amarna Therapeutics has announced today that it has entered into a collaboration with scientists from the Progreso y Salud Foundation (FPS) at Cabimer in Seville, to jointly examine the efficacy of Amarna’s SVec™ gene delivery vector for the development of effective immunotherapies for diabetes mellitus type 1 (DM1) and multiple sclerosis (MS).

READ MORE

Horizon Discovery Introduces Single Cell RNAseq-Linked CRISPR Screening Service

Product News

Horizon Discovery Group plc has announced the addition of single cell RNAseq-linked pooled CRISPR screening to its CRISPR screening services portfolio.

READ MORE

Horizon Discovery Introduces New Stable Cell Lines To Simplify CRISPR Workflows

Product News

Horizon Discovery has announced the introduction of its stably expressing Cas9 and dCas9-VPR cell lines to help accelerate gene knockout and gene activation experiments, respectively.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE